Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7445 USD | +0.30% | -8.09% | -31.06% |
02/04 | North American Morning Briefing : Stocks Seen -2- | DJ |
01/04 | BTIG Research Downgrades Sharecare to Neutral From Buy | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The company shows low valuation levels, with an enterprise value at 0.54 times its sales.
- The company appears to be poorly valued given its net asset value.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- Low profitability weakens the company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-31.06% | 270M | - | ||
+9.84% | 318B | B- | ||
+22.40% | 213B | B+ | ||
+10.74% | 56.34B | D+ | ||
+3.40% | 30.56B | B+ | ||
+2.49% | 29.48B | C+ | ||
+93.63% | 21.69B | D+ | ||
+22.42% | 20.19B | B- | ||
+5.13% | 13.66B | B | ||
+0.90% | 14.83B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SHCR Stock
- Ratings Sharecare, Inc.